Introduction
Measurements of 25-hydroxyvitamin D, which we call vitamin D, are influenced by seasonal variation and assay calibration. Vitamin D blood concentrations increase in response to sun exposure, inducing seasonal changes. These factors need to be taken into account in the analysis of matched case-control studies to associate vitamin D with disease risk. Although previous case-control analyses have used sinecosine series to account for seasonal variation [1, 2] , as we do, we have not found studies that allow for both calibration and seasonal adjustment. In this paper, we present a framework for such analyses. This framework, and parameters based on real studies, underlie our simulations to evaluate the performance of various procedures to estimate log odds ratios.
This work was motivated by collaboration on the Vitamin D Pooling Project of Breast and Colorectal Cancer (hereafter, Vitamin D Pooling Project), which includes 21 cohort studies in North America, Europe, and Asia. Because vitamin D is stable in stored frozen blood samples, such samples can be used to study associations with cancers that develop years later. Vitamin D was measured in previously stored blood from incident breast or colon cancer cases in these cohorts and from their matched controls. In some studies, the controls were tightly matched to cases on date of blood draw, but not in all studies. Moreover, different assays were used in various studies. Hence, calibration against a reference laboratory was required to put measurements from various studies on a common scale. In each study, reference laboratory measurements were obtained from 29 control bloods, selected by stratified random sampling within strata defined by deciles of the uncalibrated control vitamin D measurements. To control for effects of seasonal variation in within-study comparisons of cases and controls, study-specific seasonal adjustment was required. The intent of using calibration and study-specific seasonal adjustment is to transform the original data so that every measurement, regardless of when it was drawn and regardless of study assay, could be thought of as having been measured on the same reference date by the reference laboratory.
This work has several novel features. It provides a statistical framework to accommodate both calibration and seasonal adjustment. Using this framework, we assess procedures for inference on log odds ratios, both for continuous and categorical vitamin D risk models, in realistic simulations based on data from the Vitamin D Pooling Project. Finally, we identify practical recommendations for analysis and interpretation to inform the work of the Vitamin D Pooling Project. In particular, our analyses show the following: (1) failure to adjust for calibration and seasonal trend can inflate variance, bias, and mean square error of estimated vitamin D effects; (2) simple analytic methods can be recommended for continuous and categorical risk models (and perform even better than a theoretically appealing normal model for categorical risk); (3) with the stratified sampling design for calibration samples, there is surprisingly little increase in the variance of log odds ratio estimates from calibration and seasonal adjustment; and (4) unlike continuous vitamin D risk models, categorical models are not robust to the choice of reference date for seasonal adjustment. This finding implies that public heath recommendations for desirable vitamin D levels may need to be season specific.
Section 2 describes models and statistical methods. Section 3 describes simulation studies in which the logit of disease risk is linear or categorical in vitamin D. Section 4 presents analyses of data from three nested case-control studies, and Section 5 has concluding remarks. Technical results are given in an Appendix, and additional methods, simulations, and examples are given in the supporting information.
Methods

Motivating data
We base our simulations (Section 3) on two typical data sets, one a nested case-control study of colorectal cancer from the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study [3] , hereafter ATBC, and the second, a nested case-control study of breast cancer from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial or PLCO [4] . We use only data from controls from these studies as the basis of our simulations, and we specify the exposure effects. Figure 1 depicts vitamin D measurements in ATBC controls as a function of the week the blood sample was drawn ranging from week 1 (January 1-7) to week 52. The solid line represents a sine/cosine series fit to these data, described fully in Section 2.3. No samples were collected between weeks 24 and 32. The maximum value of the fitted curve is at week 35 (the third week in September) and the fitted values at the beginning and end of the year agree, as would make sense because they represent the same time of year. Another plot of this type is given for the PLCO data as Figure S1 . In addition to the vitamin D measurements that are available from the study-specific laboratory on all subjects, we have calibration measurements from a reference laboratory on a sample of 29 controls, selected as described in Section 2.4.
We also estimated disease associations with vitamin D from cases and controls in three studies, ATBC (Table V) , and two studies of breast cancer, the New York University Women's Health Study (NYUWHS) (Table SX) and the Cancer Prevention Study II Nutrition Cohort (CPSII) ( Table SXI) . Descriptive data for these four cohorts are in Table SI .
Statistical framework for calibration and seasonal trend models
The following notation is for a single study. Let w(t) = (t) + w be the true value of the study-specific (or 'local') assay for an individual measured at week t, where (t) is the seasonal trend in the population and w ∼ Normal(0, 2 ) represents the deviation of the individual's value from the trend. The observed local assay value is W(t) = w(t) + u W , where u W ∼ Normal(0, WW ) represents measurement error. We assumed a linear calibration curve because the regression of reference vitamin D measurements against local laboratory measurements was usually linear in Vitamin D Pooling Project studies, and in those few instances where a quadratic component was detected, differences in predictions between the linear and quadratic models were small. Under linear calibration, we denote the true value for the reference laboratory as x(t) = a + bw(t), where a and b represent the true calibration intercept and slope. The observed reference laboratory measurement would be X(t) = x(t) + u X , where u X ∼ Normal(0, XX ) is measurement error. Assuming that (w, u W , u X ) T are trivariate normal with cov(w, u X ) = cov(w, u W ) = 0 and cov(u X , u W ) = XW , it follows that the observable variables {W(t), X(t)} T are bivariate normal with means { (t), a + b (t)} T and covariance matrix
Hence, the regression of X(t) on W(t) is
E{X(t)|W(t)}
If we assume that XW = 0, as is reasonable because measurements in the local and reference laboratories on the same sample are usually performed in different locations and/or times, the regression reduces to
E{X(t)|W(t)} = E{x(t)|W(t)}
where W = 2 ( 2 + WW ) −1 is an attenuation factor (or intraclass correlation) from measurement error in W(t). Local assay values W(t) are available on all samples, whereas reference laboratory values X(t) are available only on a sample of controls, as described in Section 2.4. We assume XX and WW are known from reliability studies in which the same sample is repeatedly analyzed on different days in the reference and local laboratories. Data from the studies in the Vitamin D Pooling Project indicate that ( XX ) 1∕2 and ( WW ) 1∕2 each ranged from 0.5 to 9 nmol/L, with most values in the range of 2-4. To estimate 2 and hence W , we subtracted WW from the empirical variance of {W(t) −̂(t)} in controls, wherê(t) is the estimated periodic trend in W(t). Because 2 was much larger than WW , results were little changed in sensitivity analyses as XX and WW ranged from 4 to 36. In Section 2.3, we describe how we fit the trend.
Fitting the trend
We used data on W(t) from controls to estimate the seasonal trend (t) by fitting the model
where ∼ Normal(0, 2 ) is independent of (t) and t is in weeks. Such periodic series have been studied previously (e.g., [5] ) and shown to fit vitamin D data as an outcome variable with t in days [6] and as an exposure in case-control analyses with t in months [1, 2] . Those vitamin D analyses used only the first three terms in Equation (4), but we found that five terms were needed to fit the data well in each of the 21 Vitamin D Pooling Project studies. Figure 1 shows the fit to data from the controls in the ATBC colorectal case-control study. This approach has the advantages that only 5 degrees of freedom are used to fit the trend, which has little impact on the variance of risk estimates (Supporting Information Appendices A.5 and A.6), and the trend gives similar values on December 31 as on January 1, as is desirable. When we tried other more flexible fitting methods, such as splines with many knots or LOESS regression, the trends were not necessarily equal at the beginning and end of the year, and the variance of estimates of vitamin D effects were inflated, as previously noted [7] . Controls were used for fitting seasonal trends because, for low-incidence diseases like breast or colorectal cancer, controls are representative of the general population (see the rare disease assumption in the Supporting Information Appendix A.1). Matching controls to cases on cancer risk factors such as age changes the age distribution in controls but would not alter the seasonal vitamin D pattern in controls appreciably unless this was strongly associated with age.
Estimating the calibration parameters (a and b)
The Vitamin D Pooling Project included calibration samples from controls within each study. For each study, the control values of W(t) were grouped into deciles, and from each decile, three controls were selected at random. (In fact, 29 controls were usually selected this way, rather than 30, but for the simulations later, we selected three from each decile.) Blood samples from the selected controls were then sent to the reference laboratory for measurement of X(t). Thus, the {X(t), W(t)} pairs are a stratified random sample with strata defined by deciles of W(t). We considered three estimates of the calibration parameters a and b.
• Estimatesâ 1 andb 1 are obtained from simple linear regression of X(t) on W(t) in the calibration data. These quantities are not consistent for a and b, in view of Equation (2).
• From Equation (2), a somewhat more refined estimate (â 2 ,b 2 ) T is obtained by regressing X(t) on W {W(t) −̂(t)}.
• The most justifiable estimate, in view of Equation (2), is (â 3 ,b 3 ) T , which is obtained by regressing X(t) on̂(t)(1 −̂W ) +̂WW(t). For̂W equal 1, this procedure reduces to the regression of X(t) on W(t).
We evaluated each of these approaches in simulations. 
where x 0 ≡ x(t 0 ) = a + bw(t 0 ) is the value that the true reference laboratory would have produced if it had been measured on the reference date t 0 instead of the date t. Each matched case-control pair makes the following contribution to the conditional likelihood:
However, we only get to observe W(t), not x 0 . One approach is to replace x 0 by its conditional expectation given W(t) in Equation (2), which we estimate bŷ
The estimateŝ(⋅),â, andb are described in Sections 2.3 and 2.4. Then (7) leads to the estimated differencex
Under the rare disease assumption, and using Equation (8), if one substitutes {W(t case ) − W(t cont ) − (t case ) +̂(t cont )} for (x 0,case − x 0,control ) in Equation (6) and maximizes the conditional likelihood with respect to 1 , one obtains the estimatê * 1 of
The asymptotic behavior of̂1 is derived in the Supporting Information Appendix A.6. A simple estimate of its variance is obtained as follows. First, estimate the variance of̂ * 1 by the inverse of the Hessian of the conditional log-likelihood, and call thisVar(̂ * 1 ). Then, by the delta method,̂1 has approximate variance estimateVar(̂1) = (b̂W) −2V ar(̂ * 1 ) + (̂ * 1 ∕b 2̂W ) 2V ar(b) whereVar(b) is estimated from the regressions in Section 2.4. In this calculation, we use the fact that̂ * 1 andb are independent, and we assume that the variation from estimates of trend and̂W is numerically negligible (Supporting Information Appendix A.6). Some intuition is obtained by considering the ATBC example. Even if the case and control had t case = t cont , Var[{W(t case ) − W(t cont )}] ⩾ 2 2 = 2 × 240.9 = 481.8, which greatly exceeds the variance of the difference in trend estimates. For example, Var{̂(39∕52) −̂(1∕52)} = 10.9, which is much smaller than 481.8. Likewise, the standard error of̂W was 0.0066 in simulations, implying small variation about W = 0.9377 with WW = 16.
Importantly, none of these calculations depend on the calibration intercept a. The seasonal adjustment in Equation (8) vanishes if the case and control are matched on the date of blood draw so that t case = t cont . Also, the seasonal adjustment in (8) does not depend on the reference date, t 0 . Ignoring calibration and measurement error in W(t) is equivalent to usinĝ * 1 instead of̂1.
Categorized risk models. For categorical vitamin D, we assume
where c 0 = 0 and 1 = 0. For 1:1 nested case-control matching, the corresponding conditional likelihood contribution from a case-control pair is
where C (x) is a 5 × 1 vector of indicators in (9) for cases ( = 1) and controls ( = 0) and is the corresponding vector of log odds ratios, i . A linear trend risk model sets i = (i − 1) , where is the log odds increase in risk per exposure category increase. The contribution to the likelihood for the linear model is Equation (10) with (i − 1) replacing T C (x 0 ). The cut-points c i could be externally defined levels, such as those given by the Institute of Medicine for vitamin D [8] . They could also be study-wide quantiles of vitamin D estimated from controls from all participating studies. In the simulations in Section 3.3, they were quintiles of x 0 values among controls from the particular study on which the simulations were based. In particular, we set x 0 = a + b{W(t) −̂(t) +̂(t 0 } where W(t) and̂(⋅) were from controls from that study.
If x 0 were known, we could estimate or by maximizing the product of conditional likelihoods (10) with respect to or and obtain model-based estimates of their covariance from the Hessian of the log-likelihood. Withx 0 defined in (7), we proceeded by substitutingx 0 for x 0 in Equation (10) and by estimating covariances from the Hessian as if x 0 were known. We investigated the operating characteristics of this approach in simulations.
Although the preceding estimation procedures are easy to describe and implement, they do not take full advantage of the assumed normal distributions, nor do they acknowledge the uncertainty in assigning risk category based onx 0 instead of x 0 . Given a, b, (⋅), and
where
For a rare disease, the conditional likelihood corresponding to a matched case-control set is shown in Appendix A.1 to be
The product of such terms over case-control pairs can be maximized with respect to in the general model or (the per category log odds ratio) in the linear trend model to obtain estimates and their model-based estimated covariance. We substituted estimateŝ(⋅),â, andb to compute pr{x 0 in i|W(t)} in Equation (11). A more precise analysis might maximize the average likelihood over the distribution of (⋅),â, andb. A numerical approach would be to draw repeated samples of̂(⋅),â, andb to compute an average likelihood and maximize this quantity, but we have not pursued it because unreported simulations indicated that substitution of̂(⋅),â, andb yields similar operating characteristics as using the exact quantities (⋅), a, and b.
Simulations
Simulation setup
In this section, we describe methods to simulate realistic case-control samples based on controls from the colorectal cancer case-control study in ATBC. We also used these methods for simulations based on the breast cancer case-cohort study in PLCO. We describe the analytic procedures for continuous and categorical risk models.
Data from the controls were used to estimate the distribution of times of blood draw, the trend (t), and 2 . In particular we estimated 2 = 240.89 assuming WW = 16. The estimated coefficients in the seasonal trend Equation (4) We generated 10,000 case-control studies based on the original ATBC data. For each simulated study, we generated a large (N = 50,000) source population as follows. First, draw a date t of blood by sampling with replacement from the dates in the original controls. Then, generate w(t) = (t)+w by sampling from w ∼ Normal(0, 2 ). Set x 0 = a+bw(t 0 ) = a+b{ (t 0 )+w} and generate the disease status indicator Y from Equation (5) for continuous vitamin D and from Equation (9) for categorical vitamin D. Generate the observed local vitamin D measurement from W(t) = w(t) + u W by drawing from u W ∼ Normal(0, WW ), where WW is assumed known, and independently generate reference laboratory measurements X(t) = x(t) + u X = a + bw(t) + u X by drawing from u X ∼ Normal(0, XX ) with XX known. Implicitly, we are assuming XW = 0. At this stage, we have N triples {Y, W(t), X(t)} T .
To obtain the case-control data, we randomly selected n triples from among the triples with Y = 1 (cases) and n triples from among those with Y = 0 (controls). However, we observed X(t) only in the calibration sample, which is obtained by arranging the W(t) values of controls into decile groups and selecting three controls at random from among the controls in each decile group. For these 30 controls, which we call the calibration sample, we observed {Y, W(t), X(t)} T , but in all other cases and controls, we only observed {Y, W(t)} T . These triplets and doublets constituted the case-control data available for analysis. The effects of matching variables on risk cancel from the conditional logistic likelihood. We assumed that the matching variables have no effect on risk in these simulations, because there are no matching effects in Equations (5) and (9) . Hence, we randomly matched cases with controls to obtain n pairs, regardless of season.
Analysis of each such simulated data set for continuous vitamin D proceeded as follows. First, obtain (t) by fitting Equation (3) to the n control values of W(t). Next estimate 2 by subtracting WW from the variance of W(t) -̂(t) in controls. Usê2 and the assumed known value WW to calculatêW. Let̂ * 1 be the estimate obtained from conditional logistic regression (CLR) using the residuals {W(t) −̂(t)}. We described three estimates of (a, b) T in Section 2.4 and used these results to produce three estimates of 1 , namely,̂1 =̂ * 1 ∕b̂W , withb beingb 1 ,b 2 , orb 3 . We also present estimates from CLR with raw values W(t) and with only seasonally adjusted values, {W(t) −̂(t)}. Finally, we present an estimate based on calibration only that is obtained by dividing the estimate from the raw values, W(t), byb 1̂W . All these estimates were compared with estimates obtained by inserting the true values x 0 from the case and matched control into the CLR. None of these estimates depends on a standard reference date, t 0 .
For categorical vitamin D, values of Y were generated from Equation (9) based on quintiles of x 0 from the study on which the simulation was based, as described in Section 2.5.2 . A benchmark analysis used the perfect categories in Equation (10) based on the true x 0 , which is unknown in practice. We also categorized the raw values W(t) without seasonal adjustment or calibration for use in Equation (10), as well as the seasonally adjusted but not calibrated values, W(t) −̂(t) +̂(t 0 ) and the calibrated but not seasonally adjusted valuesâ 1 +b 1 W(t). Two more principled estimatesx 0 were used for categorization in Equation (10) . We call themx 01 =â 1 +b 1̂( t 0 )+b 1̂W {W(t)−̂(t)} andx 03 =â 3 +b 3̂( t 0 )+b 3̂W {W(t)− (t)}. A final estimate of log odds ratios, called the 'normal model' estimate, was based on Equations (11) and (12) withâ 3 +b 3̂( t 0 ) +b 3̂W {W(t) −̂(t)} and̂=b 3 ( WŴW ) 1∕2 substituted for corresponding parameters to compute z i .
Analysis of continuous vitamin D
In this section, we compare procedures with calibration and/or seasonal adjustment for analyzing continuous vitamin D. Table I contains comparisons for the various estimators of slope under the null hypothesis 1 = 0. The logistic intercept was = −4. The parameters were chosen to provide a severe test of the various procedures. In particular, there were only n = 100 case-control pairs; larger numbers of n make it easier to estimate trends and reduce small sample bias in estimators. The values a = 5 and b = 1.4 represent more severe miscalibration of the local assay than found in most Vitamin D Pooling Project studies. The estimated measurement error variances XX = WW = 16 are representative of values found in replication Table I . Simulation performance of procedures for conditional logistic regression analysis of continuous vitamin D based on data from the Alpha-Tocopherol, Beta-Carotene study at the null hypothesis 1 = 0, with n = 100 case-control pairs. n is the number of case-control pairs; a is the calibration curve intercept (a = 5); b is the calibration curve slope (b = 1.4); CI% is the estimated coverage of a 95% nominal confidence interval for 1 ; 1 is the log odds ratio increase per increase in vitamin D by one standard deviation ( = 15.5206); XX = WW is the measurement error variances ( WW = 16); 'SE' is the empirical estimate of standard error based on simulations; 'SE ratio' is the ratio of the empirical SE estimate to the mean model-based estimate of standard error; 'Var ratio' is the square of the ratio of the empirical SE for an estimator to the empirical SE of the estimate based on known exposure; 'MSE ratio' is the ratio of the mean square error from a given procedure to that based on known exposure; 'Calibration only' is defined in Section 3.1.
studies. All the estimates (even those based on the true values x 0 ) were very slightly upwardly biased, with most bias values near 4 × 10 −5 , but biases were about twice this high in analyses of the true (but unknown) x 0 values, of raw vitamin D data, and of calibrated data without seasonal adjustment. All the biases were small, however, in comparison with the empirical estimates of the standard error of the estimates; see the column headed 'SE(̂1)'. The squared ratios of empirical standard error to the empirical standard error for the true data x 0 (see column headed 'Var ratio') were near 1.1 for each of the methods that adjusted for both seasonality and calibration, 0.964 for the method based on calibration only, 1.912 for the method that adjusted for season only, and 1.665 for the raw data. Thus, there was about a 10% efficiency loss, measured as a variance ratio, for the methods that adjust for season and calibration. The corresponding ratios of mean square errors were almost identical to the variance ratios, because the bias was negligible. All procedures yielded coverage near the nominal 95% level. However, with 10,000 simulations, the 95% confidence interval is approximately equal to the estimated coverage plus or minus 0.43%. Hence, some of the coverage rates are statistically significantly less than 95%, although only very slightly less than nominal. This probably reflects the fact that the ratios of the empirical estimates from simulations of the standard error of̂1 to the average model-based estimates of standard error range from 1.028 to 1.053 (see the column headed 'SE ratio'). For example, if the ratio of the true SE to the estimated SE is 1.04, the coverage of the nominal 95% confidence interval at the null hypothesis would be Φ(1.96∕1.04)−Φ(−1.96∕1.04) = 0.9405, where Φ is the standard normal distribution function. Although the model-based variance estimates allow for variability in estimates of calibration parameters, they do not take variability in estimation of the trend into account. With n = 200 case-control pairs, this problem disappeared, as shown in Table SII , where all coverages were within 0.43% of the nominal 95%. With the larger samples, the efficiency loss from calibration and seasonal adjustment was again about 10% (Table SII) . In summary, under the null hypothesis, all procedures had nominal coverage for n = 200 and very near nominal coverage for n = 100. The efficiency loss from calibration and seasonal adjustment was about 10%, compared with the ideal situation with known x 0 , but the loss in efficiency was much greater for procedures that do not calibrate the local assay data. Table II contains comparisons under the alternative 1 = −0.04466, which corresponds to a halving of risk for an increase in vitamin D of = 15.52 nmol/L, which is the estimated standard deviation of w in the ATBC data. The coverages of all procedures that adjust for season and calibration were within 0.43% of the nominal 95% level and therefore did not deviate statistically significantly from it. Analyses of the raw vitamin D data, data that are seasonally adjusted but not calibrated, and data that are calibrated but not seasonally adjusted led to coverage significantly below nominal levels. Such coverages are even smaller with n = 200 case-control pairs (Table SIII) . Biases from failure to calibrate contributed importantly Here, CI% represents the actual coverage of a 95% nominal confidence interval. Also, 1 is the log odds ratio per increase in vitamin D by one standard deviation ( = 15.5206); XX = WW is the measurement error variances ( WW = 16); a = 5; b = 1.4. 'SE' is the empirical estimate of standard error based on simulations. 'SE ratio' is the ratio of the empirical SE estimate to the mean model-based estimate of standard error. 'Var ratio' is the square of the ratio of the empirical SE for an estimator to the empirical SE of the estimate based on known exposure. 'MSE ratio' is the ratio of the mean square error from a given procedure to that based on known exposure.
to the mean squared error ratios (Tables II and SIII) . With n = 100, all the procedures that adjusted for seasonality and calibration had comparatively small bias and losses in efficiency compared with analysis with known x 0 , with variance ratios ranging from 1.112 to 1.192 (Table II) . With n = 200, the variance ratios ranged from 1.207 to 1.385 (Table SIII) . Unreported simulations indicated similar results when WW was misspecified as 36 when the true value was 16 and for other values of the calibration parameters.
These simulations suggest that simple procedures that adjust for seasonality and calibration will perform well in practice. In particular, the deattenuated estimateŝ1 =̂ * 1 ∕b 1̂W and̂1 =̂ * 1 ∕b 3̂W had favorable bias and efficiency characteristics.
Analysis of categorical vitamin D
Recall that for j = 1, 2, 3,x 0j =â j +b ĵ( t 0 ) +b ĵW {W(t) −̂(t)}, and is the log odds per category increase.
The cut-points used to generate the relative risks from Equation (9) were the quintiles of the control values x 0 for t 0 = 39 in ATBC, namely, 49.6, 58.7, 70.8, and 86.9 nmol/L (Section 2.5.2). The intercept was = −4. Table III summarizes performance under the null hypothesis with n = 100 cases and matched controls. As for the continuous vitamin D analyses, we assumed realistic estimates of measurement error, XX = WW = 16, and substantial miscalibration with intercept a = 5 and b = 1.4. In Tables III and IV , the labels 'CLR using (10) withx 01 ' and 'CLR using (10) withx 03 ' denote procedures that substitute the calibrated and seasonally adjusted estimates of x 0 , namely,x 01 andx 03 , into the conditional likelihood Equation (10) . The 'normal model' procedure used Equations (11) and (12). These three procedures that adjust for season and calibration had near nominal coverage for 2 , 5 , and (Table III) as well as for the log odds 3 and 4 (not shown). Adjustment for calibration alone yielded near nominal coverage. Coverage for 5 was above nominal levels for analyses of raw values and for seasonal adjustment only. Table III . Simulation performance of procedures for conditional logistic regression analysis of categorical vitamin D based on data from the Alpha-Tocopherol, Beta-Carotene study at the null hypothesis i = (i−1) = 0, with n = 100 case-control pairs. 
)
Here, (â 1 ,b 1 ) and (â 3 ,b 3 ) are different calibration parameter estimates as described in Section 2 and Table I . Here, a = 5 and b = 1.4 are the calibration curve intercept and slope, respectively; XX = WW = 16 are the measurement error variances. 'SE' is the empirical estimate of standard error based on simulations. 'MSE ratio' is the ratio of the mean square error from a given procedure to that based on known exposure. 2 , 5 , and are respectively the log odds ratios corresponding to the second quintile group, fifth quintile group, and per quintile category increase (trend). The reference date was t 0 = 39/52 (week 39). The 20th, 40th, 60th, and 80th percentiles of control measurements adjusted to t 0 were 49.61, 58.73, 70.80, and 86.89 nmol/L, respectively.
Large bias was seen for seasonal adjustment alone for and 5 . Standard errors for̂5 and̂were larger for the raw data analysis and for seasonal adjustment alone than for CLR using (10) withx 01 orx 03 . The mean square error ratios (compared with the analysis with perfect x 0 data) indicated poor performance for raw data and seasonal adjustment only. For estimating 2 , the normal model had higher mean square error than CLR using (10) withx 01 orx 03 , primarily because it had larger standard error. The higher variability of̂2 from the normal model is not the result of estimating trend parameters, calibration parameters, or W , as shown in unreported simulations using known values for these parameters. Similar results were obtained with n = 200 cases and controls (Table SIV), except that subnominal coverage of 2 was found for the raw data and seasonal adjustment only. These results were obtained with the reference date t 0 = 39 weeks. Similar results were obtained with t 0 = 1, in which quintiles were re-estimated to correspond to the new reference date (unreported data). Results were little affected if the variances for measurement error were mistakenly set at XX = WW = 36, when in fact XX = WW = 16 (unreported data).
Under the alternative i = (i − 1) , with = −0.25log(2) = −0.17329, similar results were found. With n = 100 cases and controls (Table IV) , the coverage was near the nominal 95% level except for some analyses with raw data and with seasonal adjustment only. Bias was comparatively large for analysis of the raw data, seasonal adjustment only, and the normal model. Standard errors were comparatively large for the normal model. The mean square error ratios were large for raw data analysis, seasonal adjustment only, and the normal model for̂2. Similar results were found for n = 200 cases and controls (Table  SV) . Results were little affected by misspecifying XX = WW = 36, when in fact XX = WW = 16 (unreported data).
Additional simulations based on PLCO data support these findings for continuous and categorical analyses and are in Tables SVI-SIX. To summarize, CLR using (10) withx 01 and CLR using (10) withx 03 outperformed other procedures. CLR using (10) withx 03 usually had smaller MSE than CLR using (10) withx 01 , however, not only under Table IV . Simulation performance of procedures for conditional logistic regression analysis of categorical vitamin D based on data from the Alpha-Tocopherol, Beta-Carotene study at the alternative hypothesis i = (i − 1) , with = −0.25log(2) = −0.17329 and with n = 100 case-control pairs. 
Here, (â 1 ,b 1 ) and (â 3 ,b 3 ) are different calibration parameter estimates as described in Section 2 and in Table I . Here, a = 5 and b = 1.4 are the calibration curve intercept and slope, respectively; XX = WW = 16 are the measurement error variances. 'SE' is the empirical estimate of standard error based on simulations. 'MSE ratio' is the ratio of the mean square error from a given procedure to that based on known exposure. 2 , 5 , and are respectively the log odds ratios corresponding to the second quintile group, fifth quintile group, and per quintile category increase (trend). The reference date was t 0 = 39/52 (week 39). The 20th, 40th, 60th, and 80th percentiles of control measurements adjusted to t 0 were 49.61, 58.73, 70.80, and 86.89 nmol/L, respectively. the null hypothesis (Tables III, SIV, and SVIII) but also under the alternative (Tables IV, SV, and SIX) . Thus, we recommend CLR using (10) withx 03 .
Examples of analyses of three studies
We present analyses for the colorectal case-control study in ATBC [3] and for two case-control studies of breast cancer, the NYUWHS [9] and a study from the CPSII Nutrition Cohort [10] . Table V Table V . Conditional likelihoods (6), (10) , and (12) were modified to accommodate varying numbers of matched controls per case. We analyzed the data with two different reference dates for seasonal adjustment to assess the robustness of the conclusions. With week 39 as the reference date, the preferred analyses of the categorical data based on CLR using (10) withx 03 indicated a strong protective effect of increased vitamin D with a statistically significant odds ratio of exp(−1.97) = 0.139 for the highest category (⩾75 nmol/L). Indeed, the log odds ratios for all categories above the reference category (<30 nmol/L) were statistically significantly less than 0; the categorical trend with odds per category increase of exp(−0.175) = 0.839 was not statistically significant. Analyses based on CLR using (10) withx 01 were not stable because only six cases and two controls were categorized below 30 nmol/L. Note that analyses without any adjustment, with seasonal adjustment alone and with calibration alone also indicated protective trends, but the parameter estimates were smaller and usually not statistically significantly different from 0 in the absence of seasonal adjustment. The continuous trend analysis, which does not depend on a reference date, indicated a statistically significant protective odds ratio of exp(−0.143) = 0.866 per 10 nmol/L increase in vitamin D concentration. When these data were re-analyzed using week 1 as the reference date, the magnitudes of the protective effects in categorical analyses were smaller, but the qualitative conclusion of a significant protective effect remained unchanged. For example, the estimated protective odds ratio for vitamin D ⩾75 nmol/L was exp(−1.25) = 0.287, instead of the previous 0.139. Analyses based on a linear trend in continuous vitamin D were unchanged. Categorical analyses of the NYUWHS breast cancer data (893 cases and 1642 controls) with a reference date of week 39 suggested a slight favorable effect from increasing vitamin D levels, in line with the analysis based on a linear trend in continuous vitamin D (Table SX) . Re-analysis with week 1 as the reference date yielded similar small favorable categorical effects that were not statistically significant. Analyses of continuous vitamin D were unchanged.
We performed similar analyses for breast cancer data from CPSII (515 cases and 515 controls) (Table SXI) . With week 39 as the reference date, categorical analyses suggested a slight protective effect of increasing vitamin D, whereas the continuous analysis indicated a slight adverse effect. None of these effects were statistically significant, however. With week 1 as the reference date, categorical effects were less protective. However, all these estimates were consistent with the null hypothesis of no vitamin D effect.
These examples illustrate that for externally selected cut-points, such as the Institute of Medicine guidelines, estimates of category-specific log odds ratios are affected by the choice of reference date for seasonal adjustment, unlike analyses of a continuous linear trend.
Discussion
We presented a framework for seasonal adjustment and calibration of matched case-control data and used this framework to evaluate analytic procedures for continuous and categorical vitamin D risk models. We evaluated the procedures though simulations based on the Vitamin D Pooling Project data. Several practical conclusions and recommendations follow from this work: (1) adjustment for calibration and seasonal trends yields more nearly nominal coverage of confidence intervals, less bias, smaller variance, and reduced mean square error than unadjusted analyses; (2) simple procedures are available to adjust for calibration and seasonal trend; (3) for calibration samples obtained by stratified random sampling, as in the Vitamin D Pooling Project, there is surprisingly little inflation in the variance of estimates of vitamin D effects, even with only 30 calibration measurements; and (4) estimates for the logit of risk for continuous vitamin D are independent of a reference date for seasonal adjustment. In contrast, estimates for a categorical risk model depend on the reference date. Thus, public health recommendations based on vitamin D categories may need to be season specific. We elaborate on some of these points.
Simple procedures are available for seasonal adjustment and calibration to estimate the slope, 1 , of a linear trend in vitamin D on the logit of risk. First, one estimates the slope * 1 by using seasonally detrended values {W(t) −̂(t)} in place of vitamin D measurements in CLR. Then, one deattenuates and corrects for calibration by settinĝ1 =̂ * 1 ∕b 3̂W . Our methods do not adjust variances for estimating seasonal trend parameters. Nonetheless, even with n = 100 cases and controls, estimating the five seasonal trend parameters had little impact on the coverage of confidence intervals for 1 , and with n = 200, there was no evidence of impact. In Supporting Information Appendix A.6, we justify this result asymptotically. There is some loss of efficiency in estimating 1 from estimating the calibration curve, but the additional variance is accounted for in constructing confidence intervals (Section 2.5.1).
For categorical data, CLR (10) with the estimatex 03 can be recommended. In this procedure, the calibration estimates obtained by regressing X(t) on̂(t)(1 −̂W) +̂WW(t) are used, together with the seasonal trend estimate, to computex 03 from Equation (7). Then,x 03 is categorized as if it were x 0 , and the analysis proceeds using standard CLR. No special calculations were used to accommodate variation from estimating seasonal trend or calibration parameters. This procedure withx 01 in place ofx 03 worked nearly as well but is less theoretically justified because it does not take seasonal adjustment and W into account (Equation (2)) and usually has larger mean square error. For̂W = 1, however, the two procedures are equivalent. The normal model method has theoretical appeal but tended to yield more variable estimates of log odds parameters, especially 2 . This loss of efficiency seems inherent in the likelihood based on Equation (12). Unreported simulations show that even if the parameters a, b, and W are known, the normal model method yields more variable estimates than the procedures that usex 01 or x 03 in Equation (10) .
The sine-cosine series in Equation (4) fit the data well, required only five parameters, and forced the estimated trend to be periodic. Flexible procedures such as LOESS do not yield periodic trends, are more sensitive to gaps in the data, and can require many parameters, leading to increased variance of estimates of vitamin D effects [7] .
We assumed normal distributions in our analytical framework (Section 2.2). More work is needed to assess the performance of our recommended procedures for other distributions.
An important practical issue was brought out by the examples in Section 4. The Institute of Medicine guidelines for categories of vitamin D levels do not specify the time of year the blood sample was drawn. In the examples, vitamin D levels fluctuated by about 16 nmol/L between the highest values, which occurred in September-October, and the lowest values, which occurred in January-April. Thus, a person might be categorized in the highest Institute of Medicine category in September but lower in February. The intent of seasonal adjustment is to transform each person's vitamin D value to the value that person would have had if measured on a common reference date, such as week 39 or week 1. This improves comparability between cases and controls, especially in studies without matching on date of blood draw. The odds ratios depend on the choice of reference date (Appendix A.2). Thus one should specify the reference date used for categorical analyses applied to fixed cut-points. If, instead of using externally determined cut-points such as the Institute of Medicine categories, one standardizes the control data to {W(t) −̂(t) +̂(t 0 )} and chooses study-specific cut-points as percentiles of the standardized control data, then the categorical analysis is much less sensitive to choice of reference date, t 0 , as indicated by unreported simulations. Analysis of continuous vitamin D as a linear trend is not affected by choice of reference date.
An alternative to picking a particular reference date, t 0 , is to average the seasonal estimatê(t 0 ) over the 52 weeks of the year. Because integrated sinusoidal terms vanish over the year, this is equivalent to replacinĝ(t 0 ) bŷ0, the estimated intercept in Equation (4) . The resulting log odds estimates for Q 2 , Q 3 , and Q 4 for the data in Table V from Equation (10) withx 03 were −1.176, −1.160, and −1.582, respectively, and are intermediate between the values shown in Table V for reference weeks t 0 = 39 (high vitamin D levels) and t 0 = 1 (low vitamin D levels).
To summarize, simple methods for calibration and seasonal adjustment yield reliable inference for matched case-control data on vitamin D, with only modest loss of statistical efficiency, compared with analyses with perfectly known vitamin D. These findings are informing analytic approaches for the Vitamin D Pooling Project.
Appendix A
A.1. Justification for the normal model Equation (12)
Let the categories be (C 1 , … , C 5 ), and write the risk model (9) as
where H(u) = {1 + exp(−u)} −1 is the logistic function. Assuming that Y is conditionally independent of W(t) given that x is in category c,
Consider the matched pairs problem, with the matching effect i belonging to the ith matched pair, with responses (Y i1 , Y i2 ), predictors (x i1 , x i2 ), and {W i1 (t), W i2 (t)}. We have that
Under the rare disease approximation H(
which equals Equation (12).
A.2. Impact of seasonal trend adjustment, miscalibration, and variation in cut-points on categorical odds ratios
If fixed cut-points are used to define categories of exposure, then a change in the cut-points, a change in the reference date for seasonal adjustment, or miscalibration will induce bias in odds ratios with respect to the original model.
Changing the cut-points
For simplicity, we assume only two categories, but the arguments extend to multiple categories. We assume initially that the true exposure at reference date t 0 , namely, x 0 = x + (t 0 ), is known (no measurement error and no miscalibration). Suppose that x 0 > c defines the high-risk group and x 0 ⩽ c the low-risk group. Let p 1 be the risk of disease in the high-risk group and p 0 be the risk of disease in the low-risk group. The odds ratio is OR = {p 1 ∕(1 − p 1 )}∕{p 0 ∕(1 − p 0 )}. Now, suppose we choose another cut-point c * . Let F be the distribution of x 0 in the population and f be the density of x 0 . Suppose that the risk in the population is determined by the model where Y = 1 indicates diseased. The portion in curly brackets is a special case of Equation (9) (A.5)
